https://doi.org/10.29046/TBJ.003.1.014">
  •  
  •  
 

Abstract

Purpose: The clinical course of patients diagnosed with non-small cell lung cancer (NSCLC) with brain metastases (BM) at presentation is variable. Here we seek to identify predictors of survival in patients staged with FDG-PET/CT.

American Association of Physicists in Medicine (AAPM) 52nd Annual Meeting July 18-22, Philadelphia, PA

Included in

Oncology Commons

Share

COinS
https://doi.org/10.29046/TBJ.003.1.014">